Overexpression or knockdown of eIF4E by RNA intervention modulated tumor cell growth and chemosensitivity to cisplatin both in vitro and in vivo, which suggested that eIF4E might have a great potency of synergistic effect of cisplatin to ameliorate drug resistance in ESCC and many other tumors. This evidence concerns the gene EIF4E and neoplasm.